Related references
Note: Only part of the references are listed.Oral atenolol therapy for proliferating infantile hemangioma A prospective study
Yi Ji et al.
MEDICINE (2016)
Is cardiovascular evaluation necessary prior to and during beta-blocker therapy for infantile hemangiomas? A cohort study
Martine F. Raphael et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma
C. Leaute-Labreze et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Atenolol versus propranolol for the treatment of infantile hemangiomas: A randomized controlled study
Alvaro Abarzua-Araya et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Treatment of infantile haemangiomas with atenolol: Comparison with a historical propranolol group
M. de Graaf et al.
JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY (2013)
Propranolol and Infantile Hemangiomas Four Years Later: A Systematic Review
Ann L. Marqueling et al.
PEDIATRIC DERMATOLOGY (2013)
Initiation and Use of Propranolol for Infantile Hemangioma: Report of a Consensus Conference
Beth A. Drolet et al.
PEDIATRICS (2013)
Early Growth of Infantile Hemangiomas: What Parents' Photographs Tell Us
Megha M. Tollefson et al.
PEDIATRICS (2012)
Scoring the proliferative activity of haemangioma of infancy: the Haemangioma Activity Score (HAS)
S. R. Janmohamed et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2011)
A Novel Approach to Gathering and Acting on Relevant Clinical Information: SCAMPs
Rahul H. Rathod et al.
CONGENITAL HEART DISEASE (2010)
Propranolol for severe hemangiomas of infancy
Christine Leaute-Labreze et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Growth characteristics of infantile hemangiomas: Implications for management
Linda C. Chang et al.
PEDIATRICS (2008)
Prospective study of infantile hemangiomas: Clinical characteristics predicting complications and treatment
Anita N. Haggstrom et al.
PEDIATRICS (2006)
Share Paper
